Online CME: Hematology/Oncology
Last Updated February 6, 2010.
Special Notice!! Looking for reviewers to help keep the List up-to-date. |
The sites described on this page are primarily for hematologists and oncologists and other physicians concerned with hematology and cancer. You may find additional online CME sites and courses concerned with hematology and cancer at the main online CME site. |
AML Tour
(Cyberounds Acute Myeloid Leukemia in the Elderly) |
The program is in the form of a bicycle tour game. Upon completion of this activity, you should be able to discuss the incidence, prevalence and survivor rates for adult AML (acute myeloid leukemia); discuss the advantages and disadvantages of available therapies for adult AML; discuss the results of clinical trials in adult AML; describe the role of PCR and FISH in diagnosis, treatment and follow-up; and describe the mechanisms of action of potential new treatments. |
Baylor
Oncology |
Barriers to Sexual Health after Gynecologic Cancers: What Should be Done?; and Gynecologic and Colorectal Cancer: Risks and Benefits of Contraceptive Methods. |
CA - A Cancer Journal for Clinicians |
Each issue contains several articles offering 0.5 or 1.0 hours of credit. Some recent articles are: Dying, Dignity, and New Horizons in Palliative End-of-Life Care; Breast Cancer Staging; ACS Guidelines for Early Cancer Detection; Information Technology and Cancer Prevention; Concepts in the Prevention of Adenocarcinoma of the Distal Esophagus and Proximal Stomach; Staging of Non-Hodgkin Lymphoma; and Multimodality Approaches for Pancreatic Cancer. In order to take the quizzes, you must first obtain a username, password and customer number and then register with your personal information. |
Cancer
Control: Journal of the Moffitt Cancer Center
|
This site contains full-text online versions of articles from a peer-reviewed cancer journal. Each issue focuses on one type of cancer and contains four or more major articles. A new issue comes out every two months. Currently, only one of these issues offers 2 credits of CME: Enhancing Survival Outcomes in the Management of Patients With Higher-Risk Myelodysplastic Syndromes. Each module contains a set of 20 post-test questions; you need to score at least 75% to earn credit. |
CancerNetwork.com
|
Click on CME Courses/Meetings, and register or log on to access
the instruction. There appear to be 5 kinds of activities:
|
Cleveland
Clinic Bone Marrow Failure Syndromes: Optimizing Outcomes Worldwide
|
This series was recorded during a live satellite symposium at the ASH Annual Meeting in December 2008. The goal of this series is to review the pathobiology of bone marrow disorders, describe the variations in disease patterns across global regions, and evaluate the rationale for therapies and their evidence based, clinically relevant application. |
Cleveland
Clinic Kidney Cancer Highlights
|
Lecture titles: Current Role of Cytoreductive Nephrectomy; Initial Systemic Therapy Options; Management of Small Renal Masses: The Role of Percutaneous Biopsy; and Management of Small Renal Masses: What is the Best Management Option in this Case? |
Cleveland Clinic:
Reaching New Heights: Preventing Venous Thromboembolism Throughout the
Continuum of Care |
This activity focuses on clinical practices for Venous Thromboembolism ( VTE) prophylaxis in the medical, cancer and orthopedic patient. For each type of patient you will find a didactic presentation, a case presentation and a panel discussion. |
Clinical
Care Options Oncology |
About 40 text-based or case-based-interactive activities concerned with aspects of cancer. All of these categories offer CME credit: Conference Coverage, Journal Options, Management Series, Treatment Updates, Annual Updates and Interactive Cases. Not all activities offer CME (look for the term, "CME-certified"). |
CML Challenge (Cyberounds-Chronic
Myelegenous Leukemia) |
The Cyberounds® CML Links is an interactive golf program on new pharmacologic treatment and approaches to patients with chronic myelogenous leukemia (CML). Go to the Cyberrounds main page and click on Free CME at our CML Links to enter the program. |
Colonial Classic (Colorectal
Cancer) | The Colonial is an interactive golf game from Cyberounds. It concerns the evaluation and management of colorectal cancer with special emphasis on adjuvant chemotherapy. Upon completion of this activity you should be able to discuss the role of adjuvant chemotherapy for Stage IIB colorectal cancer; compare and contrast the types of chemotherapy for IIB; select chemotherapy for adjuvant treatment; describe the role of EGFR testing prior to use of EGFR blocking therapy; and describe the role of VEGF monoclonal antibodies in metastatic colorectal cancer. |
Creative
Educational Concepts
|
13 of 19 activities are concerning multiple myeloma; the other 6 are sprinkled throughout other medical subjects. |
DiagnosticImaging.com
|
A single course, The Adjuvant Treatment of Breast Cancer, offers 3.0 hours of credit. |
GliomaEd.com
|
A series of about 10 activities on the diagnosis and treatment of glioma and glioblastoma. |
Head and Neck Interventional (Cyberounds)
|
The Cyberounds® Head and Neck Interventional is an interactive program on the treatment and management of head and neck cancer. Go to the Cyberrounds main page and click on Free CME at our Head and Neck Interventional to enter the program. |
HemostasisCME.org | You will find 6 CME activities relating to hemostasis and coagulation issues: Congenital Hemophilia With Inhibitors: Treatment of Bleeding; Hemostatic Strategies in Surgery to Optimize Control of Blood Loss; Coagulation Case Challenge; Acquired Factor VIII Inhibitors: Pathophysiology and Treatment; Unexpected Bleeding Diatheses: Diagnosis and Management; and Optimizing Blood Management in Cardiovascular Surgery: Why & How. |
Hollywood Arcade (Cyberrounds -
Metastatic Breast Cancer) |
The instruction is presented in the form of a pinball game. After completing this activity, you should be able to: discuss the current management of taxane-resistant metastatic breast cancer; describe recent clinical trials involving newer taxanes and newer chemotherapy (e.g., capecitabine); describe recent clinical trials involving novel agents, e.g., epothilones, as monotherapy or in combination with capecitabine for the treatment of taxane-resistant, metastatic breast cancer; and discuss the mechanisms of action of the various proposed new agents. |
InforMEDical Oncology CME | Three programs currently offered: Advances in Treating Metastatic Bone Cancer; Advancing Treatment of Bladder Cancer; and Novel Agents in the Treatment of Lung Cancer: Assessing Opportunities for Combination Therapy. |
Medscape
Hematology-Oncology
|
CME activities of special interest to hematologists and oncologists. Medscape
contains a variety of educational formats:
|
MelanomaCare.org |
You will find 10 webcasts/podcasts; the newest are: Melanoma: A Mysterious Disease?; Scientific and Clinical Interpretation of New Data on IFN-a for Adjuvant Therapy of Melanoma; Signal Transduction Inhibitors in Melanoma; Update on histologic and molecular markers for melanoma;
and Optimizing imaging studies for baseline assessment and surveillance of melanoma.
You will also find 5 text publications on various aspects of melanoma
management. You must fax or mail completed test questions in order to receive
CME credit. |
Meniscus
Limited
|
There are 4 activities at this time: CINV (chemotherapy-induced nausea and vomiting): Using Evidence-Based Practice to Improve Patient Outcomes; Critical Decision Making in Health Care-Associated Infections: Managing Serious Pediatric Infections; Systemic Chemotherapy for Breast Cancer: Issues in Preoperative and Adjuvant Treatment; and Special Report: Supportive Care Issues in Cancer No. 2. |
MyCME.com Oncology Courses from Johns Hopkins
|
One new course per month. Recent activities include: Non-Small Cell Lung Cancer Management based on EGFR Mutation Status; Colorectal Cancer and Evidence for Cure by Adjuvant Chemotherapy; Oncofertility in Clinical Practice; Evidence for the Use of Circulating Tumor Cells in the Prognostic Stratification of Women with Metastatic Breast Cancer; and Carcinoma of Unknown Primary: Changing Paradigm in the Era of Molecular Profiling. |
(The)
Oncologist
|
"Over 200" courses in a wide variety of hematology and oncology areas. Some major areas are: Acute and Chronic Leukemias and Multiple Myeloma; Breast Cancer; Cancer Biology; Clinical Pharmacology; Gastrointestinal Cancer; Genitourinary Cancer; Lung Cancer; Lymphoma; Radiation Oncology; Schwartz Center Rounds; and Symptom Management and Supportive Care. Some newer activities are: Contemporary Imaging in Sarcoma; The Assessment and Management of Delirium in Cancer Patients; Plasma Fibrinogen Levels and Prognosis in Patients with Ovarian Cancer; and Should Patients With High-Risk Soft Tissue Sarcoma Receive Adjuvant Chemotherapy? |
Oncology
E-Learning Center (formerly Imedex)
|
A variety of courses in oncology. Topics covered are: Breast; Gastrointestinal; General Oncology; Genitourinary; Hematology; and Lung. |
OnsiteInsight |
There are currently 2 issues of OnsiteInsight. The latest issue covers topics coming out the recent European Society of cardiology, held in September 2008. The previous issue covers the American College of Cardiology (ACC) Scientific Sessions in April 2008. Both concern platelets and clotting issues. |
OptumHealth Education |
The slide-video lectures currently available are in the following areas: Cardio (6), Infectious Disease (3), Gastroenterology (1), Neuroscience (32), and Oncology (9). |
Projects
in Knowledge Advanced Certificate Program: Breast Cancer Management
II
|
After completing this course, you should be able to: apply evidence-based guidelines to determine optimal treatment interventions for patients with or at risk for developing breast cancer through an understanding of the epidemiology, risk factors, and disease burden imposed by breast cancer, including genetic factors, dietary modification, morbidity, and mortality; assess the role of genetic and other markers in determining optimal treatment selection in breast cancer patients, and in evaluating treatment response to therapy to improve patient outcomes; evaluate the appropriate use of chemotherapy, hormone therapy, and targeted therapy agents in treatment strategies for breast cancer patients that improve outcomes through knowledge of their efficacy and safety; and assess the challenges in promoting treatment compliance, including long-term compliance, and address the long-term consequences of treatment. |
Projects In Knowledge Advanced Certificate Program IV: Bridging Cultural Differences to Improve HBV Treatment in Asian and Other Diverse Communities
|
The fourth year of this program features 19 courses presented online over one year, and offers up to 18 credits. The curriculum contains the latest information on HBV virology and genotyping, screening and diagnosis in the Asian community, AASLD, Keeffe, and APASL hepatitis B virus treatment guidelines, and current and emerging treatment strategies. It will also help clinicians understand the impact of cultural differences in the management of HBV infection, with particular focus on the Asian and Pacific Islander communities. |
Projects
In Knowledge Advanced Certificate Program in Hepatocellular Carcinoma
|
After completing this course, you should be able to: assess the importance of screening, surveillance, diagnosis, and optimal treatment intervention of patients with or at risk of developing HCC (hepatocellular carcinoma) through an understanding of the risk factors, disease burden, imaging, and biomarkers to customize interventions leading to improved patient outcomes; analyze the benefits of liver transplantation, surgical resection and ablation therapies in eligible patients with HCC to optimize patient outcomes; compare the benefits of various adjunctive therapies, including ablative therapy, radiofrequency ablation (RFA) and chemoembolization; as well as conformal or stereotactic radiation, including radiotherapeutic microspheres, to select single or combined strategies that improve outcomes of patients with HCC; evaluate the benefits of targeted therapeutic agents, based on their efficacy and safety profiles and mechanisms of action, to improve treatment outcomes in patients with HCC; assess tumor- and patient-related factors as predictors of response to determine which patients with HCC are likely to benefit from specific therapies to improve their outcomes; and describe the potential role of systemic chemotherapies in combination with targeted agents, in the future treatment of patients with HCC. |
Projects
in Knowledge Advanced Certificate Program: Lung Cancer Management
|
This 12-month curriculum explores both non-small-cell lung cancer (NSCLC) as well as small cell lung cancer (SCLC) with respect to Guidelines, Assessing at-risk individuals, Screening, Diagnosis, Staging and Treatment. Current and emerging innovative treatment options and strategies in lung cancer are emphasized, such as chemotherapy (including newer agents such as paclitaxel, pralatrexate and talotrexin), chemoradiation, neoadjuvant and adjuvant chemotherapy), consolidative chemotherapy, targeted therapies (including vascular endothelial growth factor [VEGF] inhibitors, epidermal growth factor [EGFR] inhibitors, matrix metalloprotease (MMP) inhibitors, farnesyl transferase [FT] inhibitors, multikinase inhibitors, inhibitors of Ras, HDAC, mTOR, Met, MEK, toll and p13K, that include gefitinib, erlotinib, bevacizumab, sunitinib, sorafenib, lonafarnib, vandetanib and cetuximab). |
Projects in Knowledge Certificate Program in
Advanced/Metastatic Colorectal Cancer
|
After completing this course, you should be able to: determine the importance of environmental, dietary, and hereditary risk factors associated with the development of colorectal cancer; analyze the guidelines/recommendations and options for treatment of patients with stage two and stage three colon and rectal cancer; assess the first-line and subsequent treatment options available for patients with metastatic colorectal cancer; and evaluate the options available for multimodal management of patients with resectable metastatic colorectal cancer.
|
Projects In Knowledge Living Medical Textbook Hematology Edition: Insights into Managing Leukemia
|
Three chapters at present: Overview of Leukemia; Lymphoid Leukemia; and Myeloid Leukemia. |
Texas Medical Association’s Physician Oncology Education Program (POEP) | The five activities are: Ovarian Cancer: Designed for the Primary Care Physician (1.0 hour); Pain Primer for Primary Physicians (1.5 hours); Performance Improvement (PI) Continuing Medical Education Project for Primary Care Physicians (20 hours); Survivorship (Lance Armstrong Foundation: Professional Training Opportunities) (hours not stated); and Tobacco Intervention and the Health Care Provider (1.0 hour). |
TumorAblationClinic.com
|
Four articles on the use of radiofrequency (RFA) and cryoablation in the treatment of various tumors: RFA and cryoablation offer safe, effective treatment of bone tumors; Ablation of kidney tumors can treat nonsurgical candidates; RFA in lung cancer: promising results in safety and efficacy; and Expanded treatment of hepatic tumors is possible with RFA and cryoablation. Read all 4 articles before taking the test for CME credit (4 hours). |